MedTrace Logo

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT07741656 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-08-03

No results posted yet for this study

Summary

This single-arm study aims to evaluate the Beacon Platform, an advancement in urological surgery. The study will assess its intraoperative and postoperative outcomes. The aim of this investigation is to establish safety and performance of the Beacon Platform.

Conditions

  • BPH (Benign Prostatic Hyperplasia)
  • HoLEP (Holmium Laser Enucleation of Prostate)

Interventions

DEVICE

Beacon Platform

Procedure is performed using the Beacon Platform

Sponsors & Collaborators

  • Andromeda Surgical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-26
Primary Completion
2026-12-31
Completion
2027-01-31

Countries

  • Bulgaria
  • Chile
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07741656 on ClinicalTrials.gov